Frazier Life Sciences Management, L.P. — 13F Holdings

2026 Q3  ·  47 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Frazier Life Sciences Management, L.P. maintained a portfolio of 47 distinct positions. The most significant new addition was ATTOVIA THERAPEUTICS INC, now representing 3.00% of the total fund value. They heavily accumulated shares in MANNKIND CORP, increasing the position by 138.7%. Conversely, Frazier Life Sciences Management, L.P. completely exited their position in BRIDGEBIO PHARMA INC.
Position History hover any row below to update
Loading…
Frazier Life Sciences Management, L.P. Seattle, WA Life Sciences Venture Capital / Growth Equity AUM $4,031M
PCA Score Concentration Risk
Risk ENB
Total Positions
47
Quarter
2026 Q3
Top Holding
MIRM (16.3%)
Top 10 Concentration
70.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-47 of 47

Frazier Life Sciences Management, L.P. Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
MIRM
MIRUM PHARMACEU...
Healthcare 16.29% 19.58% #1
Prev: #1
7.0
—
no change no change
P
S
7,679,684 $656,459,388 2022 Q1 13F Filing 2026-09-30 2026-11-16
NAMS
NEWAMSTERDAM PH...
Healthcare 11.46% 13.35% #2
Prev: #2
6.0
—
900,000 5.0%
P
S
18,988,902 $461,810,097 2022 Q4 13F Filing 2026-09-30 2026-11-16
ERAS
ERASCA INC
Healthcare 10.72% 9.96% #3
Prev: #3
7.0
—
4,500,000 18.0%
P
S
29,475,188 $432,106,256 2024 Q2 13F Filing 2026-09-30 2026-11-16
MBX
MBX BIOSCIENCES...
Healthcare 9.67% 8.00% #4
Prev: #4
5.4
—
no change no change
P
S
6,652,013 $389,941,002 2024 Q3 13F Filing 2026-09-30 2026-11-16
ARQT
ARCUTIS BIOTHER...
Healthcare 6.48% 5.64% #5
Prev: #5
4.1
—
no change no change
P
S
9,874,511 $260,983,326 2022 Q1 13F Filing 2026-09-30 2026-11-16
MAZE
MAZE THERAPEUTI...
Healthcare 3.56% 3.27% #6 2
Prev: #8
1.9
—
250,000 5.0%
P
S
5,282,915 $143,589,630 2025 Q1 13F Filing 2026-09-30 2026-11-16
TRVI
TREVI THERAPEUT...
Healthcare 3.39% 4.04% #7 1
Prev: #6
1.9
—
-400,300 -4.0%
P
S
9,539,147 $136,600,585 2022 Q2 13F Filing 2026-09-30 2026-11-16
KRYS
KRYSTAL BIOTECH...
Healthcare 3.23% 3.90% #8 1
Prev: #7
1.8
—
-89,988 -18.7%
P
S
391,319 $130,137,047 2022 Q1 13F Filing 2026-09-30 2026-11-16
PVLA
PALVELLA THERAP...
Healthcare 3.02% 2.94% #9 1
Prev: #10
2.2
—
no change no change
P
S
882,400 $121,709,432 2024 Q4 13F Filing 2026-09-30 2026-11-16
N/A
ATTOVIA THERAPE...
Unknown 3.00% — #10
Prev: #—
4.7
—
7,046,271 —
NEW
7,046,271 $120,773,085 — 13F Filing 2026-09-30 2026-11-16
BRVE
BRAVEHEART BIO ...
Healthcare 2.64% — #11
Prev: #—
4.6
—
5,267,321 —
NEW
5,267,321 $106,399,884 2026 Q3 13F Filing 2026-09-30 2026-11-16
PHAT
PHATHOM PHARMAC...
Healthcare 2.26% 2.95% #12 3
Prev: #9
1.9
—
no change no change
P
S
12,466,489 $91,005,370 2022 Q1 13F Filing 2026-09-30 2026-11-16
PBLS
PARABILIS MEDIC...
Healthcare 1.87% 1.14% #13 4
Prev: #17
3.2
—
409,945 21.3%
P
S
2,330,750 $75,259,918 2026 Q2 13F Filing 2026-09-30 2026-11-16
DYN
DYNE THERAPEUTI...
Healthcare 1.54% 1.53% #14
Prev: #14
3.1
—
700,000 22.2%
P
S
3,853,082 $62,073,151 2023 Q4 13F Filing 2026-09-30 2026-11-16
ACHV
ACHIEVE LIFE SC...
Healthcare 1.53% 1.08% #15 4
Prev: #19
1.6
—
no change no change
P
S
7,614,836 $61,604,023 2026 Q2 13F Filing 2026-09-30 2026-11-16
MNKD
MANNKIND CORP
Healthcare 1.52% 0.61% #16 11
Prev: #27
3.6
—
9,155,491 138.7%
P
S
15,755,491 $61,446,415 2025 Q4 13F Filing 2026-09-30 2026-11-16
IRON
DISC MEDICINE I...
Healthcare 1.52% 2.16% #17 5
Prev: #12
0.6
—
-420,000 -31.0%
P
S
934,852 $61,195,412 2023 Q2 13F Filing 2026-09-30 2026-11-16
TARS
TARSUS PHARMACE...
Healthcare 1.40% 1.00% #18 4
Prev: #22
1.1
—
-8,306 -1.1%
P
S
720,338 $56,625,770 2022 Q1 13F Filing 2026-09-30 2026-11-16
VOR
VOR BIOPHARMA I...
Healthcare 1.30% 1.02% #19 1
Prev: #20
2.5
—
200,000 7.9%
P
S
2,743,939 $52,354,356 2025 Q4 13F Filing 2026-09-30 2026-11-16
ASND
ASCENDIS PHARMA...
Healthcare 1.27% 1.31% #20 5
Prev: #15
1.5
—
no change no change
P
S
225,155 $51,297,064 2024 Q3 13F Filing 2026-09-30 2026-11-16
ZLAB
ZAI LAB LTD
Healthcare 1.24% 0.79% #21 5
Prev: #26
1.5
—
no change no change
P
S
1,902,320 $50,107,109 2025 Q1 13F Filing 2026-09-30 2026-11-16
ACRS
ACLARIS THERAPE...
Healthcare 1.14% 0.57% #22 7
Prev: #29
3.5
—
3,804,142 77.2%
P
S
8,729,516 $45,917,254 2022 Q1 13F Filing 2026-09-30 2026-11-16
AURA
AURA BIOSCIENCE...
Healthcare 1.11% 1.10% #23 5
Prev: #18
1.4
—
no change no change
P
S
7,100,000 $44,588,000 2025 Q2 13F Filing 2026-09-30 2026-11-16
ALLO
ALLOGENE THERAP...
Healthcare 0.89% 1.02% #24 3
Prev: #21
1.4
—
no change no change
P
S
22,446,668 $35,914,669 2024 Q1 13F Filing 2026-09-30 2026-11-16
BCRX
BIOCRYST PHARMA...
Healthcare 0.83% 0.87% #25 2
Prev: #23
1.3
—
no change no change
P
S
4,009,240 $33,396,969 2026 Q1 13F Filing 2026-09-30 2026-11-16
CLDX
CELLDEX THERAPE...
Healthcare 0.72% — #26
Prev: #—
3.8
—
900,080 —
NEW
900,080 $29,171,593 2026 Q3 13F Filing 2026-09-30 2026-11-16
ACAD
ACADIA PHARMACE...
Healthcare 0.72% 0.79% #27 2
Prev: #25
1.3
—
no change no change
P
S
1,438,198 $28,979,690 2022 Q3 13F Filing 2026-09-30 2026-11-16
STTK
SHATTUCK LABS I...
Healthcare 0.63% 0.57% #28 2
Prev: #30
1.3
—
no change no change
P
S
3,750,000 $25,575,000 2026 Q2 13F Filing 2026-09-30 2026-11-16
IMCR
IMMUNOCORE HLDG...
Healthcare 0.62% 0.34% #29 7
Prev: #36
3.2
—
344,970 71.2%
P
S
829,752 $25,133,188 2024 Q2 13F Filing 2026-09-30 2026-11-16
DSGN
DESIGN THERAPEU...
Healthcare 0.56% 0.57% #30 2
Prev: #28
1.2
—
no change no change
P
S
1,809,854 $22,749,865 2024 Q2 13F Filing 2026-09-30 2026-11-16
EOLS
EVOLUS INC
Healthcare 0.52% 0.40% #31 4
Prev: #35
1.2
—
no change no change
P
S
2,630,665 $21,045,320 2025 Q2 13F Filing 2026-09-30 2026-11-16
SRPT
SAREPTA THERAPE...
Healthcare 0.48% — #32
Prev: #—
3.7
—
1,069,959 —
NEW
1,069,959 $19,494,653 2026 Q3 13F Filing 2026-09-30 2026-11-16
RLAY
RELAY THERAPEUT...
Healthcare 0.45% 0.41% #33 1
Prev: #34
1.2
—
no change no change
P
S
1,015,693 $18,333,259 2026 Q2 13F Filing 2026-09-30 2026-11-16
LXEO
LEXEO THERAPEUT...
Healthcare 0.40% 0.49% #34 1
Prev: #33
1.2
—
no change no change
P
S
4,824,725 $16,307,571 2024 Q3 13F Filing 2026-09-30 2026-11-16
VALN
VALNEVA SE
Healthcare 0.35% 0.26% #35 2
Prev: #37
1.1
—
no change no change
P
S
2,291,666 $14,173,954 2025 Q2 13F Filing 2026-09-30 2026-11-16
KLRA
KAILERA THERAPE...
Healthcare 0.34% 0.53% #36 5
Prev: #31
2.1
—
100,000 9.1%
P
S
1,200,000 $13,704,000 2026 Q2 13F Filing 2026-09-30 2026-11-16
GLUE
MONTE ROSA THER...
Healthcare 0.30% 0.53% #37 5
Prev: #32
1.1
—
no change no change
P
S
1,000,000 $11,930,000 2026 Q1 13F Filing 2026-09-30 2026-11-16
ORIC
ORIC PHARMACEUT...
Healthcare 0.25% — #38
Prev: #—
3.6
—
751,672 —
NEW
751,672 $10,125,022 2023 Q2 13F Filing 2026-09-30 2026-11-16
AUTL
AUTOLUS THERAPE...
Healthcare 0.21% 0.15% #39
Prev: #39
1.1
—
no change no change
P
S
4,447,910 $8,628,945 2022 Q1 13F Filing 2026-09-30 2026-11-16
NAMSW
NEWAMSTERDAM PH...
Unknown 0.16% 0.23% #40 2
Prev: #38
1.1
—
no change no change
P
S
500,333 $6,329,212 2022 Q4 13F Filing 2026-09-30 2026-11-16
SVRA
SAVARA INC
Healthcare 0.14% 1.30% #41 25
Prev: #16
0.1
—
-8,607,100 -88.5%
P
S
1,113,752 $5,746,960 2023 Q3 13F Filing 2026-09-30 2026-11-16
XLO
XILIO THERAPEUT...
Healthcare 0.09% 0.09% #42 2
Prev: #40
1.0
—
no change no change
P
S
422,505 $3,823,670 2025 Q4 13F Filing 2026-09-30 2026-11-16
N/A
TCGX ACQUISITIO...
Unknown 0.09% — #43
Prev: #—
3.5
—
300,000 —
NEW
300,000 $3,753,000 — 13F Filing 2026-09-30 2026-11-16
IBIO
IBIO INC
Healthcare 0.06% 0.07% #44 3
Prev: #41
1.0
—
no change no change
P
S
1,953,467 $2,305,091 2025 Q4 13F Filing 2026-09-30 2026-11-16
ALKS
ALKERMES PLC
Healthcare 0.00% 0.80%
Sold All 😨
(Was: #24)
0.0
—
-700,647 -100.0%
CLOSED
— $— 2024 Q3 13F Filing 2026-09-30 2026-11-16
CYTK
CYTOKINETICS IN...
Healthcare 0.00% 2.15%
Sold All 😨
(Was: #13)
0.0
—
-1,159,879 -100.0%
CLOSED
— $— 2025 Q2 13F Filing 2026-09-30 2026-11-16
BBIO
BRIDGEBIO PHARM...
Healthcare 0.00% 2.51%
Sold All 😨
(Was: #11)
0.0
—
-1,548,139 -100.0%
CLOSED
— $— 2023 Q1 13F Filing 2026-09-30 2026-11-16
Showing 1-47 of 47 holdings

Unlock Full Frazier Life Sciences Management, L.P. Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →